Richard K. Bestwick

Person

Bend, OR, US

People

Patents Grantslast 30 patents

Information Patent Grant
Exon skipping compositions for treating muscular dystrophy
- Patent number 11,932,851
- Issue date Mar 19, 2024
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotide analogues targeting human LMNA
- Patent number 11,802,283
- Issue date Oct 31, 2023
- Sarepta Therapeutics, Inc.
- Michael R. Erdos
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Exon skipping oligomer conjugates for muscular dystrophy
- Patent number 11,491,238
- Issue date Nov 8, 2022
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Processes for preparing oligomers
- Patent number 11,384,105
- Issue date Jul 12, 2022
- Sarepta Therapeutics, Inc.
- Baozhong Cai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antisense-induced exon2 inclusion in acid alpha-glucosidase
- Patent number 11,236,338
- Issue date Feb 1, 2022
- Sarepta Therapeutics, Inc.
- Stephen Donald Wilton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oligonucleotide analogues targeting human LMNA
- Patent number 11,071,749
- Issue date Jul 27, 2021
- Sarepta Therapeutics, Inc.
- Ryszard Kole
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense-induced exon exclusion in myostatin
- Patent number 11,015,200
- Issue date May 25, 2021
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Exon skipping compositions for treating muscular dystrophy
- Patent number 10,907,154
- Issue date Feb 2, 2021
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes for preparing oligomers
- Patent number 10,875,880
- Issue date Dec 29, 2020
- Sarepta Therapeutics, Inc.
- Baozhong Cai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oligonucleotide analogues targeting human LMNA
- Patent number 10,822,608
- Issue date Nov 3, 2020
- Sarepta Therapeutics, Inc.
- Michael R. Erdos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Exon skipping oligomer conjugates for muscular dystrophy
- Patent number 10,758,629
- Issue date Sep 1, 2020
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oligonucleotide analogues targeting human LMNA
- Patent number 10,076,536
- Issue date Sep 18, 2018
- Sarepta Therapeutics, Inc.
- Ryszard Kole
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide analogues targeting human LMNA
- Patent number 9,682,097
- Issue date Jun 20, 2017
- Sarepta Therapeutics, Inc.
- Ryszard Kole
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Exon skipping compositions for treating muscular dystrophy
- Patent number 9,217,148
- Issue date Dec 22, 2015
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide analogues targeting human LMNA
- Patent number 9,066,967
- Issue date Jun 30, 2015
- Sarepta Therapeutics, Inc.
- Ryszard Kole
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oligonucleotide compound and method for treating nidovirus infections
- Patent number 8,759,307
- Issue date Jun 24, 2014
- Sarepta Therapeutics, Inc.
- David A. Stein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for treating enterovirus or rhinovirus infection using antis...
- Patent number 8,524,676
- Issue date Sep 3, 2013
- Sarepta Therapeutics, Inc.
- David A. Stein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antisense composition and method for treating cancer
- Patent number 7,402,574
- Issue date Jul 22, 2008
- AVI BioPharma, Inc.
- Patrick L. Iversen
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Simultaneous collection of DNA and non-nucleic analytes
- Patent number 6,309,827
- Issue date Oct 30, 2001
- Orasure Technologies, Inc.
- Andrew S. Goldstein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20240042049
- Publication date Feb 8, 2024
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20230104708
- Publication date Apr 6, 2023
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20220364093
- Publication date Nov 17, 2022
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20220259592
- Publication date Aug 18, 2022
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
- Publication number 20220251551
- Publication date Aug 11, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE
- Publication number 20220170024
- Publication date Jun 2, 2022
- Sarepta Therapeutics, Inc.
- Stephen Donald Wilton
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN
- Publication number 20220090084
- Publication date Mar 24, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20220056442
- Publication date Feb 24, 2022
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20220017901
- Publication date Jan 20, 2022
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR PREPARING OLIGOMERS
- Publication number 20210198296
- Publication date Jul 1, 2021
- Sarepta Therapeutics, Inc.
- Baozhong CAI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
- Publication number 20210187003
- Publication date Jun 24, 2021
- Sarepta Therapeutics, Inc.
- Diane Elizabeth FRANK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20210180064
- Publication date Jun 17, 2021
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20210138078
- Publication date May 13, 2021
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
- Publication number 20210010001
- Publication date Jan 14, 2021
- Sarepta Therapeutics, Inc.
- Michael R. Erdos
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20200339985
- Publication date Oct 29, 2020
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY
- Publication number 20200190516
- Publication date Jun 18, 2020
- Sarepta Therapeutics, Inc.
- Frederick Joseph SCHNELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
- Publication number 20200147119
- Publication date May 14, 2020
- Sarepta Therapeutics, Inc.
- Ryszard Kole
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROCESSES FOR PREPARING OLIGOMERS
- Publication number 20200040020
- Publication date Feb 6, 2020
- Sarepta Therapeutics, Inc.
- Bao CAI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20200040336
- Publication date Feb 6, 2020
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
- Publication number 20190365918
- Publication date Dec 5, 2019
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20190330624
- Publication date Oct 31, 2019
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY
- Publication number 20190262375
- Publication date Aug 29, 2019
- Sarepta Therapeutics, Inc.
- Diane Elizabeth FRANK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20190177724
- Publication date Jun 13, 2019
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
- Publication number 20190127735
- Publication date May 2, 2019
- Sarepta Therapeutics, Inc.
- Michael R. Erdos
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN
- Publication number 20180355358
- Publication date Dec 13, 2018
- Sarepta Therapeutics, Inc.
- Frederick Joseph Schnell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE
- Publication number 20180216111
- Publication date Aug 2, 2018
- Sarepta Therapeutics, Inc.
- Stephen Donald WILTON
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA
- Publication number 20180092938
- Publication date Apr 5, 2018
- Sarepta Therapeutics, Inc.
- Ryszard Kole
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20180016574
- Publication date Jan 18, 2018
- Sarepta Therapeutics, Inc.
- Richard K. Bestwick
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20180002689
- Publication date Jan 4, 2018
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20170369875
- Publication date Dec 28, 2017
- Sarepta Therapeutics, Inc.
- Richard K. BESTWICK
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Richard K. Bestwick

Person

Patents Grantslast 30 patents

Exon skipping compositions for treating muscular dystrophy

Oligonucleotide analogues targeting human LMNA

Exon skipping oligomer conjugates for muscular dystrophy

Processes for preparing oligomers

Antisense-induced exon2 inclusion in acid alpha-glucosidase

Oligonucleotide analogues targeting human LMNA

Antisense-induced exon exclusion in myostatin

Exon skipping compositions for treating muscular dystrophy

Processes for preparing oligomers

Oligonucleotide analogues targeting human LMNA

Exon skipping oligomer conjugates for muscular dystrophy

Oligonucleotide analogues targeting human LMNA

Oligonucleotide analogues targeting human LMNA

Exon skipping compositions for treating muscular dystrophy

Oligonucleotide analogues targeting human LMNA

Oligonucleotide compound and method for treating nidovirus infections

Method for treating enterovirus or rhinovirus infection using antis...

Antisense composition and method for treating cancer

Simultaneous collection of DNA and non-nucleic analytes

Patents Applicationslast 30 patents

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE

ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

PROCESSES FOR PREPARING OLIGOMERS

EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPY

OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA

PROCESSES FOR PREPARING OLIGOMERS

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING OLIGOMERS FOR MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA

ANTISENSE-INDUCED EXON EXCLUSION IN MYOSTATIN

ANTISENSE-INDUCED EXON2 INCLUSION IN ACID ALPHA-GLUCOSIDASE

OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY

EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY